Clinical Study

Usefulness of Change in Estimated Glomerular Filtration Rate as a Predicting Factor of Progression of Chronic Kidney Disease

Table 2

Basic characteristics of remission and no-remission groups.

Remission groupNo-remission groupP

Gender; no. of patients (%) 0.042
 Female 9 (20.9%) 29 (41.4%)
 Male 34 (79.1%) 41 (58.6%)
Age; years 65.8 ± 12.8 ( ) 68.6 ± 11.0 ( ) 0.221
Underlying disease; no. of patients (%)0.421
 Non-diabetic 31 (72.1%) 44 (62.9%)
 Diabetic12 (27.9%) 26 (37.1%)
CKD stage; no. of patients (%) 0.194
 III 5 (11.6%) 3 (4.3%)
 IV 25 (58.1%) 37 (52.9%)
 V 13 (30.2%) 30 (42.9%)
eGFR; mL/min/1.73 m220.8 ± 8.6 ( ) 17.3 ± 6.1 ) 0.026
serum creatinine; mg/dL3.0 ± 1.5 ( ) 3.0 ± 1.0 ( ) 0.914
Total protein; g/dL7.2 ± 0.7 ( ) 7.0 ± 0.7 ( ) 0.126
Albumin; g/dL3.9 ± 0.6 ( ) 3.8 ± 0.5 ( ) 0.697
Urea nitrogen; mg/dL 38.7 ± 13.1 ( ) 40.6 ± 11.8 ( ) 0.433
Uric acid; mg/dl7.4 ± 2.0 ( ) 7.0 ± 1.6 ( ) 0.239
Calcium; mg/dL9.0 ± 0.9 ( ) 8.8 ± 0.6 ( ) 0.181
Inorganic phosphate; mg/dL3.7 ± 0.8 ( ) 4.0 ± 0.8 ( ) 0.201
Total cholesterol; mg/dL200.5 ± 44.8 ( ) 196.3 ± 46.3 ( ) 0.652
Urinary protein; g/g·Cr2.1 ± 2.9 ( ) 3.6 ± 3.2 ( ) 0.036
Hemoglobin A1c; %6.5 ± 1.8 ( ) 6.2 ± 1.2 ( ) 0.400
Hemoglobin; g/dL11.6 ± 2.0 ( ) 10.7 ± 1.9 ( ) 0.013
Hematocrit; %35.7 ± 5.7 ( ) 32.9 ± 5.3 ( ) 0.009

Data are presented in means ± SD, unless stated otherwise. eGFR: estimated glomerular filtration rate.